SEC EDGAR · Insider purchase
RAPP: Silva Paul M reported buying shares
1 reported purchase of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.
Follow RAPP- Became public
- Oct 22, 2026
- Event / period date
- Oct 22, 2026
- Collected
- Nov 8, 2026, 7:56 PM EST
Why this is connected
This filing identifies Rapport Therapeutics, Inc. as the issuer of the security. The company's SEC identifier connects it to RAPP.
Reported transactions
Silva Paul M (Director)
3,680 shares · Common Stock
Oct 22, 2026 · $27.075 per share
Value calculated from the reported shares and prices: $99,636.00.
Code P covers open-market and private purchases. Grants, option exercises, and tax withholding are excluded from purchase results. Read the source footnotes for ownership and pricing details.
Source evidence
Read the source excerpt or record
<?xml version="1.0"?>
<ownershipDocument>
<schemaVersion>X0609</schemaVersion>
<documentType>4</documentType>
<periodOfReport>2026-10-22</periodOfReport>
<issuer>
<issuerCik>0002012593</issuerCik>
<issuerName>Rapport Therapeutics, Inc.</issuerName>
<issuerTradingSymbol>RAPP</issuerTradingSymbol>
<issuerForeignTradingSymbol></issuerForeignTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik>0001446372</rptOwnerCik>
<rptOwnerName>Silva Paul M</rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerNonUSAddressFlag>false</rptOwnerNonUSAddressFlag>
<rptOwnerStreet1>RAPPORT THERAPEUTICS, INC.</rptOwnerStreet1>
<rptOwnerStreet2>99 HIGH STREET, SUITE 2100</rptOwnerStreet2>
<rptOwnerCity>BOSTON</rptOwnerCity>
<rptOwnerState>MA</rptOwnerState>
<rptOwnerZipCode>02110</rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector>true</isDirector>
<isOfficer>false</isOfficer>
<isTenPercentOwner>false</isTenPercentOwner>
<isOther>false</isOther>
</reportingOwnerRelationship>
</reportingOwner>
<aff10b5One>false</aff10b5One>
<nonDerivativeTable>
<nonDerivativeTransaction>
<securityTitle>
<value>Common Stock</value>
</securityTitle>
<transactionDate>
<value>2026-10-22</value>
</transactionDate>
<transactionCoding>
<transactionFormType>4</transactionFormType>
<transactionCode>P</transactionCode>
<equitySwapInvolved>false</equitySwapInvolved>
</transactionCoding>
<transactionAmounts>
<transactionShares>
<value>3680</value>
</transactionShares>
<transactionPricePerShare>
<value>27.075</value>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value>A</value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value>3680</value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value>I</value>
</directOrIndirectOwnership>
<natureOfOwnership>
<value>By Paul M Silva 2016 Declaration of Trust U/A DTD 12/19/2016</value>
</natureOfOwnership>
</ownershipNature>
</nonDerivativeTransaction>
</nonDerivativeTable>
<ownerSignature>
<signatureName>/s/ Troy Ignelzi, Attorney-in-Fact</signatureName>
<signatureDate>2026-10-22</signatureDate>
</ownerSignature>
</ownershipDocument>Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.